Sibel Guerler

Sibel Guerler is an experienced professional in the field of pharmacovigilance and patient safety, currently serving as the Head of Strategy & Safety Evolution at Bristol Myers Squibb since November 2020. In this role, Sibel supports patient safety leadership in designing a strategic safety organization and optimizing operational models. Prior positions include Head of Innovation, Partnerships & Process Optimization and Director of Digital Insights and Innovation at Celgene, with responsibilities spanning global case management activities, project oversight, and innovation initiatives. Sibel's career also includes roles at Johnson & Johnson, focusing on vendor relationships and pharmacovigilance strategy, as well as a management position at Crucell, overseeing vaccine pharmacovigilance operations. Sibel began the professional journey as a Techtransfer Specialist at BDC-Basel after earning a Master of Science in Molecular Biology from the University of Basel.